|Bid||152.92 x 100|
|Ask||153.02 x 100|
|Day's Range||152.45 - 154.60|
|52 Week Range||133.64 - 184.21|
|PE Ratio (TTM)||14.53|
|Dividend & Yield||4.60 (2.94%)|
|1y Target Est||N/A|
An osteoporosis drug from Amgen could be derailed on cardiovascular woes, the company said Sunday — prompting Radius Health stock to spike.
Its partner and its rival have a lot riding on the fate of Evenity.
Amgen may need to do a major acquisition to revive is stock price longterm